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poor rate of career progression, lack of benefits and financial 
support from institutions and the government. 
Although RTT does not perform certain activities in the 
clinic, the clinical domains described by ESTRO CC were 
classified by most RTTs as skills and competences acquired 
during the academic degree, but may not apply on their 
clinical daily practice. 
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Purpose/Objective: To compare and quantify residual set-up 
errors for head and neck IMRT between 4DoF (translation and 
yaw) and 6DoF (translation plus pitch, roll and yaw) clinical 
accelerator couches and evaluate the impact on treatment 
time and imaging frequency. 
Materials and Methods: 30 retrospective patient records 
formed 2 groups of data for comparison. Group A (n=15) was 
treated on a traditional 4DoF Varian IGRT couch and group B 
(n=15) was treated on a Varian PerfectPitchTM 6DoF couch. 
293 CBCTs were analysed retrospectively. Each CBCT was 
registered at the superior, central and inferior level of the 
treatment volume. The differences in indicated 
displacements at each level relative to the online registered 
treatment position were recorded to indicate residual set-up 
error. Maximum shifts over the extent of the treatment 
volume in the vertical, longitudinal and lateral directions 
were averaged over the course of treatment along with their 
standard deviations. In addition, the maximum vector shift 
over the 3 registration levels was recorded for each fraction 
and averaged over the course of treatment. The time taken 
for image acquisition and analysis was recorded as were the 
number of repeat CBCTs performed. Significance testing for 
differences between groups was assessed via the t-test. 
Results: Improved setup accuracy for the 6DoF group was 
reflected through significantly smaller standard deviations of 
the maximum residual error in the vertical and longitudinal 
directions, as shown in the table below. Significantly reduced 
maximum vector shifts were also observed, from an average 
of 0.30 cm to 0.19 cm for the 4DoF and 6DoF groups 
respectively. Overall setup times for the 6DoF group were on 
average 2.4 minutes less than for the 4DoF group, as a result 
of a reduced number of repeat patient setups. 24 repeat 
CBCTs were required for the 4DoF group, due to an inability 
to correct for observed displacements, compared to 4 for the 
6DoF group. 
 
Conclusions: A significant reduction in the magnitude and 
variation of residual setup error and imaging time was 
observed when using a 6DoF robotic couch for head and neck 
IGRT. A maximum residual vector shift over the treatment 
volume of 0.19 cm for the 6DoF group is a significant 
improvement over the 0.3 cm achieved with the standard 
4DoF couch. Changes in neck flexion are common for this 
treatment site and whilst pitch rotation cannot always 
provide adequate correction, the number of repeat CBCTs 
required was found to be significantly reduced when this 
capability was available. From a resource perspective, 
significant time savings were observed when using a 6DoF 
couch. Using 15 minutes treatment slots as an example, the 
average saving of 2.4 minutes per patient found in this study 
could potentially allow 5 extra patients to be treated in an 
average 9 hour treatment day using a 6DoF couch. 
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Purpose/Objective: The control of VMAT plans is a key issue 
in the QA process. The steps in VMAT verification can be an 
independent calculation of monitor units, measurement of 
fluences or, using phantoms, measurement of point dose and 
dose distributions. This steps rely on phantoms to simulate 
the patient, with the consequent loss of realism in the 
verification. The possibility to evaluate the transit dose 
through the patient to calculate the 3D dose distribution in 
each fraction of treatment can detect some errors. 
Dosimetry Check (DC) (Math Resolutions, Columbia) is a 
commercial software for portal dosimetry which allows pre-
treatment verification and transit dose using transmitted 
fluence information gathered by the EPID. It overlaps isodose 
curves on the CT image, calculates the dose at reference 
points, reconstructs dose and gamma (Γ) volume histograms 
allowing possibility to verify the dose distribution to PTV and 
OAR and, if necessary, replanning it. 
In this study is tested the possibility to use the DC for an 
adaptive radiotherapy. 
Materials and Methods: 22 patients with prostate cancer, 6 
with head and neck and 18 with thoracic cancer were 
selected for this study. Dose calculation was performed using 
Monaco TPS (Elekta, Crawly). A VMAT plan was generated 
using a 6MV photon beam and Montecarlo optimization 
algorithm. Treatments were delivered through a MLC (4mm) 
Elekta SynergyS. Integrated images were acquired by EPID in 
continuous mode (60 frames/rotation) for the arc during the 
delivery and imported with planning CT data, associated 
structures and 3D dose matrix into DC. It uses the imported 
fluence fields to calculate the absolute dose and dose 
distribution through Pencil Beam (PB) algorithm. Analysis was 
based on the comparison between planned and delivered 
dose at isocenter (ΔD), and the calculation of Gamma Index 
(Γ). 
When a ΔD difference of 5% was found, or if there was a 
value of Γ index less than 95% for more than three days a re-
planning was considered. 
Results: Prostate cases: the ΔD is 4.9%(±4.1%). The mean Γ 
(3%;3mm) value is (95.3 ±2.3)%. In 5 cases, the Γ value is less 
than 95%, however Γ index for OARs and PTV is greater than 
95%. We deduced that the cold and hot spots were in the 
body. 
H&N cases: ΔD is 6.3%(±4.1%). Γ is 92.2%(±1.8%). In 3 cases 
the Γ is less than 90%: patients had lost weight, so it was 
necessary to re-planning it. 
Thoracic cancer: deviation ΔD is 6.5%(±4.8%). Γ passing rate 
test is 93.23%(±6.3%). Low values of Γ are due to the 
difference of the calculation algorithm between TPS and DC. 
Conclusions: DC seems to be a valid method for monitoring 
the delivering of a treatment planning and avoiding setup 
